Vikram M. Narayan, MD

Join us for our SUO Fellowship Virtual Open House on January 13, 2026, 7-8 PM EST @ssjoshi.bsky.social @emoryuroonc.bsky.social . Register here: zoom.us/meeting/regi...

Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF

Nadofaragene Firadenovec for BCG-Unresponsive CIS: Efficacy, Durability, and Practical Considerations - Vikram Narayan Zachary Klaassen speaks with Vikram Narayan from Emory University about nadofaragene firadenovec, a first-in-class gene therapy for BCG-unresponsive bladder cancer. Dr. Narayan explains how this non-r...

Thanks to Zachary Klaassen for a great conversation on BCG unresponsive non-muscle invasive #bladdercancer —working through three common, real-world patient cases to think through practical considerations on sequencing and using these new therapies.

www.urotoday.com/video-lectur...

#Quiz A 61-year-old woman presented with refractory hypercalcemia. She had obstructive uropathy secondary to bilateral ureteral stones. The stone composition was 80% calcium oxalate, 20% calcium phosphate. What was the etiology?

bit.ly/Varanasi25Quiz (FREE)

My takeaways:
-Well done study with 1000+ randomized, credit to the authors + participants
- Still a hard sell for NMIBC—AE risks warrant close collab w/ med onc despite likely push to do these in the urology clinics “bc it’s subQ”
-If you don’t have BCG, you still don’t have BCG—and this needs BCG

Results of CREST: sasanlimab+BCG in BCG naive HR NMIBC patients offers a 32% risk reduction in HR recurrence, persistent CIS, progression, or death compared to BCG alone.

www.nature.com/articles/s41...

AEs are 🤨 - Grade 3 - 29%(!!) for sasanlimab pts vs 6% for BCG
- 2 treatment related deaths

. @jackiebrownmd.bsky.social

Radiation oncologist Patricia Santos, MD, MS, @trishasantos.bsky.social shares insights on her poster highlighting “Access to cancer care for undocumented immigrants in the United States.” #ASCO25

Healthcare - Success Stories Read the success stories of how health organizations around the world use Apple technology to reduce clinician burnout and deliver personalized care.

My thanks to my #EmoryUrology family and the teams at #Apple and @hey.epic.com for helping us tell the @emoryhealthcareatl.bsky.social story of how clinician well-being is being prioritized through the use of great technology

www.apple.com/healthcare/s...

Shreyas Joshi, MD, MPH | Winship Cancer Institute of Emory University "There really aren’t many other places treating advanced bladder cancer the way we are,” says Shreyas Joshi, MD, MPH, a urologic oncologist at Winship Cancer Institute of Emory University. He speciali...

Great spotlight of my friend and colleague @ssjoshi.bsky.social , highlighting the fantastic bladder cancer work the @winshipcancer.emory.edu and Emory Urology teams are doing to help our patients and their families @emoryuroonc.bsky.social

winshipcancer.emory.edu/stories/arch...

Congratulations to our very own @tgoodstein.bsky.social for being awarded the 2025 Society of Urologic Oncology #CGOncology #NMIBC Fellowship Grant at #AUA2025 @ssjoshi.bsky.social @drnarayan.com

Congratulations to Sid Marthi @emoryuroonc.bsky.social for winning Best Poster at this morning’s Improving Access & Outcomes Across All Populations session at #AUA2025, highlighting the great collaboration between #GradyHealth, #MorehouseSM and #Emory to improve #ProstateCancer care inequities

Kudos to @amehtamd.bsky.social and colleagues for a fantastic session on vasectomy guidelines - key takeaways: fascial interposition, allow patient autonomy, and there’s no plausible biological link to prostate cancer #AUA2025

A good #AUA2025. Thank you for the invitation to present on the topic of APPs in leadership! #APPSession #Urology

Enjoying a sparks flying crossfire in treatment BCG unresponsive NMIBC, special shout out to my partner @ssjoshi.bsky.social and my friends Vig Packiam, Cheryl Lee, William Huang, and @tullikagarg.bsky.social at #AUA2025

My sincere thanks to Philipp Dahm, the University of #Minnesota Department of Urology, and the Minnesota #Urologic Society for the honor of a VP invitation—was great to see and spend time with old friends and mentors

Thanks again to Tommy Korn and everyone at Sharp Healthcare for hosting a fantastic Spatial Computing Health Care Summit - awesome to see all the amazing things people have been doing with Apple #VisionPro & to share some of what we’ve been able to do with our partners at #KarlStorz #SharpSpatial

Emory Urology

“Grateful to be at #SWIU surrounded by incredible women—friends, colleagues, and mentees. Inspired by the exchange of ideas and learning about topics that truly empower us to lead fulfilled and successful lives. Here’s to growth, community, and innovation! 🩷 #WomenInUrology” @emoryuroonc.bsky.social

Looking forward to this! DM me if interested

Interested in learning about Emory’s
#SUO fellowship?
📆 Join us for a virtual open house on Thursday, Jan 16th from 7-8 PM EST

DM or email us if you’re interested -we’ll send you a link! @ssjoshi.bsky.social @valentinagrajales.bsky.social @tgoodstein.bsky.social @winshipatemory.bsky.social

Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer - Prostate Cancer and Prostatic Diseases Prostate Cancer and Prostatic Diseases - Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancer

This study suggests that a negative PSMA PET scan can help avoid unnecessary pelvic lymph node dissection in intermediate-risk prostate cancer patients, potentially reducing treatment complications without compromising outcomes. #ProstateCancer #MedicalImaging

always double glove

Surgeons showed significantly greater manual dexterity compared with physicians, nurses, and non-clinical staff when assessed using a buzz wire game.

But had the highest rates of swearing
www.bmj.com/content/387/...

Thx again to my friend @ddshapiro.bsky.social for giving us an outstanding Grand Rounds today @emoryuroonc.bsky.social & @winshipatemory.bsky.social on #RenalMedullaryCarcinoma. Inspiring work presented in an incredibly understandable & engaging way @msaouel.bsky.social @jackiebrownmd.bsky.social

Hello all. #urology #redsox #coys #golf #newyorkgiants

Happy to meet with anyone interested in the @SUO Fellowship @uthealthsa.bsky.social

🔬 Robust research opportunities
🎓 Master's Degree
✂️ High surgical volume in open and robotic approaches

Send me a DM if interested
#SUO24

and welcome to @bsky.app to @umbreit.bsky.social ! #SUO24

Proud of our first @emoryuroonc.bsky.social SUO fellow #TaylorGoodstein making a splash in RCC research at the #SUO24 Winter Meeting

@ssjoshi.bsky.social @jackiebrownmd.bsky.social

(1/8) For those on Bluesky, I'm a uro onc @mdanderson.bsky.social specializing in prostate cancer, biomarkers, disparities, and behavioral interventions.

We're taking a tour through classic obesity literature to help inform patient counseling and future studies.